Evidence map›Paper›PMID 32075799›Full record

ReviewCancer research2020

Postpartum Involution and Cancer: An Opportunity for Targeted Breast Cancer Prevention and Treatments?

Virginia F Borges, Traci R Lyons, Doris Germain, Pepper Schedin

Open access · greenAbstract readReview
In one paragraph

Review in Cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 2 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Review
  5. Review
  6. Article
  7. Postpartum breast cancer: evidence for a distinct phenotype.Journal of the National Cancer Institute · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Impact of Postpartum Diagnosis on Survival of Women with Inflammatory Breast Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Virginia F Borges *Young Women's Breast Cancer Translational Program, University of Colorado Cancer Center, Aurora, Colorado. Schedin@ohsu.edu Virgina.borges@ucdenver.edu.ORCID 0000-0003-1158-7524
Traci R Lyons *Young Women's Breast Cancer Translational Program, University of Colorado Cancer Center, Aurora, Colorado.
Doris GermainTisch Cancer Institute, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Pepper SchedinYoung Women's Breast Cancer Translational Program, University of Colorado Cancer Center, Aurora, Colorado. Schedin@ohsu.edu Virgina.borges@ucdenver.edu.ORCID 0000-0003-4244-987X
University of Colorado Cancer Center · USIcahn School of Medicine at Mount Sinai · USOregon Health & Science University · US

Funding

NSAIDs During Postpartum Involution for Breast Cancer ChemopreventionR01CA169175 · NCI · UNIVERSITY OF COLORADO DENVER · PI SCHEDIN, PEPPER J · 2013 to 2024
$4.8M
Deciphering COX-2/SEMA7A dependent mechanisms of breast tumor progression.R01CA211696 · NCI · UNIVERSITY OF COLORADO DENVER · PI LYONS, TRACI · 2017 to 2021
$2.0M
NCI NIH HHS R01 CA169175NCI NIH HHS R01 CA211696
6 · The paper itself

Abstract

Childbirth at any age confers a transient increased risk for breast cancer in the first decade postpartum and this window of adverse effect extends over two decades in women with late-age first childbirth (>35 years of age). Crossover to the protective effect of pregnancy is dependent on age at first pregnancy, with young mothers receiving the most benefit. Furthermore, breast cancer diagnosis during the 5- to 10-year postpartum window associates with high risk for subsequent metastatic disease. Notably, lactation has been shown to be protective against breast cancer incidence overall, with varying degrees of protection by race, multiparity, and lifetime duration of lactation. An effect for lactation on breast cancer outcome after diagnosis has not been described. We discuss the most recent data and mechanistic insights underlying these epidemiologic findings. Postpartum involution of the breast has been identified as a key mediator of the increased risk for metastasis in women diagnosed within 5-10 years of a completed pregnancy. During breast involution, immune avoidance, increased lymphatic network, extracellular matrix remodeling, and increased seeding to the liver and lymph node work as interconnected pathways, leading to the adverse effect of a postpartum diagnosis. We al discuss a novel mechanism underlying the protective effect of breastfeeding. Collectively, these mechanistic insights offer potential therapeutic avenues for the prevention and/or improved treatment of postpartum breast cancer.

Indexed as

Maternal AgeNeoplasm MetastasisAdultAnimalsAntigens, CDBreastBreast FeedingBreast NeoplasmsCyclooxygenase 2Disease Models, AnimalFemaleGlobal HealthGPI-Linked ProteinsHumansIncidenceLactationAntigens, CDCyclooxygenase 2GPI-Linked ProteinsNeoplasm ProteinsPAPPA protein, humanPregnancy-Associated Plasma Protein-ASEMA7A protein, humanSemaphorins

Identifiers

PMID32075799
PMCPMC8285071
OpenAlexW3007524046

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.